In this trial, at 60 weeks, the exenatide group showed a significant improvement in MDS-UPDRS Part III scores compared to the placebo group among the 62 recruited patients (80)
10.4103/jrms.JRMS_236_20 Summary Keywords L-carnitine, glycemic markers, systematic review, meta-analysis, adult, diabetes mellitus type 2 Citation Zamani M, Pahlavani N, Nikbaf-Shandiz M, Rasaei N, Ghaffarian-Ensaf R, Asbaghi O, Shiraseb F and Rastgoo S (2023) The effects of L-carnitine supplementation on glycemic markers in adults: A systematic review and dose-response meta-analysis
(October, 2016)
These medications are used by celebrities and people who want to lose weight and maintain an ideal body weight
Based on the results of these clinical trials, Novo Nordisk submitted a new drug application for Semaglutide to the US Food and Drug Administration (FDA) in 2017 and was approved for marketing at the end of 2017